ALB and lung carcinoma: The Advanced Lung Cancer Inflammation Index (ALI), calculated as Body Mass Index (kg/m2) × Serum Albumin (g/dL)/Neutrophil-to-Lymphocyte Ratio, has been identified as a strong prognostic marker for overall survival in lung cancer patients (12).